SearchDictionaryMobileLogin

Takuya Moriya Selected Research

Carcinoma (Carcinomatosis)

07/2008Aromatase in human breast carcinoma as a key regulator of intratumoral sex steroid concentrations.
02/2008Intracrinology of estrogens and androgens in breast carcinoma.
01/2008Giant T4 rectal carcinoma mimicking urinary bladder adenocarcinoma accurately diagnosed by immunohistochemistry and successfully treated with total pelvic exenteration: Report of a case.
10/2007Analysis of surrogate markers for target-specific therapy in breast carcinomas using archival materials.
09/2007In situ production of sex steroids in human breast carcinoma.
08/2007Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.
06/2007[Recent evidence about aromatase in the breast carcinoma]
06/2007Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor.
05/2007Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor.
05/2007Ovarian epithelial carcinoma with estrogen-producing stroma.
03/2007Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays.
01/20075Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.
12/2006Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.
04/2005Immunolocalization of nuclear transcription factors, DAX-1 and Ad4BP/SF-1, in human common epithelial ovarian tumors: correlations with StAR and steroidogenic enzymes in epithelial ovarian carcinoma.
04/2005StAR and progesterone producing enzymes (3beta-hydroxysteroid dehydrogenase and cholesterol side-chain cleavage cytochromes P450) in human epithelial ovarian carcinoma: immunohistochemical and real-time PCR studies.
07/2004Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.
09/2003Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma.
06/2003Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.
04/2003Pathological assessment of intraductal spread of carcinoma in relation to surgical margin state in breast-conserving surgery.
01/2002In situ production of estrogens in human breast carcinoma.

Articles by Research Topic

Disease

20Carcinoma (Carcinomatosis)
07/2008 - 01/2002
10Breast Neoplasms (Breast Cancer)
02/2008 - 01/2003
4Neoplasms (Cancer)
10/2008 - 07/2002
3Prostatic Neoplasms (Prostate Cancer)
12/2007 - 03/2005
3Ovarian Neoplasms (Ovarian Cancer)
07/2007 - 12/2005
2Endometrial Neoplasms (Endometrial Cancer)
06/2008 - 06/2003
2Thymoma (Thymic Carcinoma)
09/2005 - 05/2003
1Noninfiltrating Intraductal Carcinoma (DCIS)
03/2008
1Adenocarcinoma
01/2008
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2008
1Endometriosis (Adenomyosis)
10/2007
1Systemic Scleroderma (Systemic Sclerosis)
09/2007
1Tissue Adhesions
09/2007
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
06/2007
1Neoplasm Metastasis (Metastasis)
04/2006
1Colonic Neoplasms (Colon Cancer)
04/2006
1Pulmonary Alveolar Proteinosis
04/2006
1Small Cell Carcinoma
07/2005
1Thyroid Neoplasms (Thyroid Cancer)
03/2003
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2003

Drug/Important Bio-Agent (IBA)

9Estrogens (Estrogen)FDA Link
02/2008 - 01/2002
5Aromatase (CYP19)IBA
07/2008 - 01/2005
5EnzymesIBA
03/2008 - 03/2005
4HormonesIBA
03/2007 - 05/2003
3Steryl-Sulfatase (Steroid Sulfatase)IBA
06/2006 - 06/2003
3estrone sulfotransferaseIBA
06/2006 - 06/2003
3Progesterone Receptors (Progesterone Receptor)IBA
07/2005 - 07/2002
2SteroidsIBA
03/2008 - 09/2007
2irinotecan (Camptosar)FDA LinkGeneric
08/2007 - 12/2006
2Cisplatin (Platino)FDA LinkGeneric
08/2007 - 12/2006
1Keratins (Keratin)IBA
10/2008
1VimentinIBA
10/2008
1tensins (tensin)IBA
06/2008
1beta CateninIBA
06/2008
1AndrogensIBA
02/2008
1capecitabine (Xeloda)FDA Link
02/2008
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
02/2008
1Thymidine PhosphorylaseIBA
02/2008
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2008
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2007
1Biological Markers (Surrogate Marker)IBA
10/2007
1GelatinIBA
09/2007
1Polyglycolic Acid (Polyglycolide)IBA
09/2007
1Paclitaxel (Taxol)FDA LinkGeneric
08/2007
1Carboplatin (JM8)FDA LinkGeneric
08/2007
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2007
1DNA methyltransferase 3AIBA
06/2007
1cyclin B1IBA
05/2007
1CyclinsIBA
03/2007
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2006
1titanium silicide (TS-1)IBA
04/2006
1OxidoreductasesIBA
04/2005
1CytochromesIBA
04/2005
1Transcription Factors (Transcription Factor)IBA
04/2005
1CholesterolIBA
04/2005
1ProgesteroneFDA LinkGeneric
04/2005
1ERRalpha estrogen-related receptorIBA
07/2004
1Biological Tumor Markers (Tumor Markers)IBA
01/2004
13 (or 17)-beta-hydroxysteroid dehydrogenaseIBA
06/2003
1progesterone receptor BIBA
06/2003
1Parathyroid Hormone-Related ProteinIBA
03/2003
1Medroxyprogesterone 17-Acetate (Depo-Provera)FDA LinkGeneric
03/2003
1Interleukin-6 (Interleukin 6)IBA
03/2003
1gefitinib (Iressa)FDA Link
01/2003
1Carcinoembryonic AntigenIBA
01/2003
1Protein Isoforms (Isoforms)IBA
07/2002

Therapy/Procedure

1Pelvic Exenteration
01/2008
1Oncolytic Virotherapy
12/2007
1Gastric Bypass (Roux-en-Y Gastric Bypass)
09/2007
1Adjuvant Chemotherapy
12/2006
1Segmental Mastectomy (Lumpectomy)
04/2003